Core Insights - Peninsula Medical has been recognized as both a "Gazelle Enterprise" and a "Potential Unicorn Enterprise" at the 2025 China (Shenzhen) Unicorn Enterprise Conference, highlighting its rapid growth and innovation in the optical medical aesthetics sector [1][2] - The company has developed the "Peninsula White Aurora," which has been awarded as a "2025 Guangdong Province Excellent High-tech Product," showcasing its commitment to technological advancement and market leadership [1][6] Group 1: Company Achievements - Peninsula Medical's growth trajectory is marked by significant technological breakthroughs, including the launch of the Peninsula Ultrasound Cannon, the first domestically approved ultrasound medical device, which disrupts the import monopoly [2][4] - The company has over 400 R&D personnel and more than 1,000 patent applications, establishing a strong foundation for innovation and market penetration [1][4] Group 2: Product Innovation - The "Cold Picosecond" device, known as "Peninsula White Aurora," features the industry's shortest pulse width of 250ps and dual-wavelength precision control, setting a new standard for domestic picosecond laser technology [6] - This product addresses specific challenges in treating Asian skin types, effectively targeting superficial pigmentation and deep tattoos, thus enhancing its market competitiveness [6][7] Group 3: Industry Ecosystem - The ecosystem in Bao'an includes 4 global unicorns, 7 Chinese unicorns, 71 gazelle enterprises, and 28 potential and seed unicorns, creating a robust network of innovation across strategic industries such as semiconductors and renewable energy [7] - The synergy of the "industrial chain, innovation chain, and capital chain" supports the efficient operation of this enterprise matrix, with over 57,000 manufacturing companies facilitating local procurement and rapid iteration [7]